Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk

被引：0
|
作者：
Liu, Shi [1 ]
Li, Yongyin [1 ]
Sun, Jian [1 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Viral Hepatitis Res, State Key Lab Organ Failure Res,Dept Infect Dis, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2022年 / 132卷 / 15期
关键词：
HEPATITIS-B;
D O I：
10.1172/JCI161134
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Association between four common microRNA polymorphisms and the risk of hepatocellular carcinoma and HBV infection
    Kou, Jian-Tao
    Fan, Hua
    Han, Dongdong
    Li, Lixin
    Li, Ping
    Zhu, Jiqiao
    Ma, Jun
    Zhang, Zhi-Hua
    He, Qiang
    [J]. ONCOLOGY LETTERS, 2014, 8 (03) : 1255 - 1260
  • [22] Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma
    Jang, Jeong Won
    Kwon, Jung Hyun
    You, Chan Ran
    Kim, Jin Dong
    Woo, Hyun Young
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Chung, Kyu Won
    [J]. ANTIVIRAL THERAPY, 2011, 16 (07) : 969 - 977
  • [23] Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-Year prospective study
    Lu, Hui
    Geng, Da Ying
    Shen, Fei
    Zhang, Jing Yao
    Lu, Bing
    Ma, Li Xian
    [J]. VIROLOGY JOURNAL, 2011, 8
  • [24] Optimization of adefovir therapy in chronic hepatitis B according to baseline predictors and on-treatment HBV DNA: a 5-Year prospective study
    Hui Lu
    Da Ying Geng
    Fei Shen
    Jing Yao Zhang
    Bing Lu
    Li Xian Ma
    [J]. Virology Journal, 8
  • [25] Histopathological features of HSPgp96 expression and its relationship with HBV-DNA in hepatocellular carcinoma
    Wu, Xinhua
    Su, Xiaoqin
    Yao, Dengfu
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A171 - A171
  • [26] RELATIONSHIP BETWEEN AGNORS AND DNA PLOIDY PATTERN IN HUMAN HEPATOCELLULAR-CARCINOMA
    MIZUNO, M
    KAGAWA, K
    MATSUMOTO, M
    SAKABE, K
    NAKAJIMA, T
    HIKITA, H
    MURATA, S
    DEGUCHI, T
    OKANOUE, T
    KASHIMA, K
    ASHIHARA, T
    [J]. HEPATOLOGY, 1991, 14 (04) : A179 - A179
  • [27] Lenvatinib treatment for advanced hepatocellular carcinoma: The relationship between efficacy and safety
    Oikawa, T.
    Yusa, K.
    Okamoto, T.
    Yonezawa, M.
    Satou, T.
    Abe, T.
    Endo, K.
    Sawara, K.
    Kuroda, H.
    Takikawa, Y.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [28] Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients
    Wan, Shaogui
    Hann, Hie-Won
    Ye, Zhong
    Hann, Richard S.
    Lai, Yinzhi
    Wang, Chun
    Li, Ling
    Myers, Ronald E.
    Li, Bingshan
    Xing, Jinliang
    Yang, Hushan
    [J]. CARCINOGENESIS, 2017, 38 (04) : 439 - 446
  • [29] Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese population
    Rebecca A. Harris
    Gang Chen
    Wen Yao Lin
    Fu Min Shen
    W. Thomas London
    Alison A. Evans
    [J]. Cancer Causes & Control, 2003, 14 : 995 - 1000
  • [30] Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese population
    Harris, RA
    Chen, G
    Lin, WY
    Shen, FM
    London, WT
    Evans, AA
    [J]. CANCER CAUSES & CONTROL, 2003, 14 (10) : 995 - 1000
12345